Arcturus Therapeutics Ltd
(ARCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,569 | -6,884 | -21,785 | -20,774 | -16,521 |
| Depreciation Amortization | 349 | 172 | 582 | 415 | 256 |
| Accounts receivable | -1,336 | 24 | -4,001 | -643 | -891 |
| Accounts payable and accrued liabilities | 773 | 1,585 | 578 | 938 | 838 |
| Other Working Capital | 9,631 | 402 | -1,156 | 4,562 | 7,897 |
| Other Operating Activity | 2,081 | -710 | 5,022 | 505 | 219 |
| Operating Cash Flow | $3,929 | $-5,411 | $-20,760 | $-14,997 | $-8,202 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 23,612 | 21,118 | 13,042 |
| PPE Investments | -344 | -78 | -1,478 | -1,253 | -1,000 |
| Investing Cash Flow | $-344 | $-78 | $22,134 | $19,865 | $12,042 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,872 | N/A | N/A |
| Common Stock Issued | 15,546 | N/A | 332 | 332 | 351 |
| Financing Cash Flow | $15,546 | $N/A | $10,204 | $332 | $351 |
| Beginning Cash Position | 36,816 | 36,816 | 25,238 | 25,238 | 25,238 |
| End Cash Position | 55,947 | 31,327 | 36,816 | 30,438 | 29,429 |
| Net Cash Flow | $19,131 | $-5,489 | $11,578 | $5,200 | $4,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,929 | -5,411 | -20,760 | -14,997 | -8,202 |
| Capital Expenditure | -344 | -78 | -1,478 | -1,253 | -1,000 |
| Free Cash Flow | 3,585 | -5,489 | -22,238 | -16,250 | -9,202 |